Literature DB >> 2275555

Purification and characterization of bovine cerebral cortex A1 adenosine receptor.

M E Olah1, K A Jacobson, G L Stiles.   

Abstract

A1 adenosine receptors (A1AR) acting via the inhibitory guanine nucleotide binding protein inhibit adenylate cyclase activity in brain, cardiac, and adipose tissue. We now report the purification of the A1AR from bovine cerebral cortex. This A1AR is distinct from other A1ARs in that it displays an agonist potency series of N6-R-phenylisopropyladenosine (R-PIA) greater than N6-S-phenylisopropyladenosine greater than (S-PIA) greater than 5'-N-ethylcarboxamidoadenosine (NECA) compared to the traditional potency series of R-PIA greater than NECA greater than S-PIA. The A1AR was solubilized in 1% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate (Chaps) and then purified by chromatography on an antagonist [xanthine amine congener (XAC)]-coupled Affi-Gel 10 followed by hydroxylapatite chromatography. Following purification, sodium dodecyl sulfate-polyacrylamide gel electrophoresis revealed a single protein of Mr 36,000 by silver staining, Na125I iodination with chloramine T and photoaffinity labeling with [125I]8-[4-[[[[2-(4-aminophenyl acetylamino) ethyl] carbonyl] methyl] oxy]-phenyl]-1,3- dipropylxanthine. This single protein displayed all the characteristics of the A1AR, including binding an antagonist radioligand [( 3H]XAC) with high affinity (Kd = 0.7 nM) and in a saturable manner (Bmax greater than 4500 pmol/mg). Agonist competition curves demonstrated the expected bovine brain A1AR pharmacology: R-PIA greater than S-PIA greater than NECA. The overall yield from soluble preparation was 7%. The glycoprotein nature of the purified A1AR was determined with endo- and exoglycosidases. Deglycosylation with endoglycosidase F increased the mobility of the A1AR from Mr 36,000 to Mr 32,000 in a single step. The A1AR was sensitive to neuraminidase but resistant to alpha-mannosidase, suggesting the single carbohydrate chain was of the complex type. This makes the bovine brain A1AR similar to rat brain and fat A1AR in terms of its carbohydrate chains yet the purified A1AR retains its unique agonist potency series observed in membranes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2275555      PMCID: PMC3476062          DOI: 10.1016/0003-9861(90)90665-l

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  18 in total

1.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

Authors:  F C GREENWOOD; W M HUNTER; J S GLOVER
Journal:  Biochem J       Date:  1963-10       Impact factor: 3.857

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Photoaffinity cross-linked A1 adenosine receptor-binding subunits. Homologous glycoprotein expression by different tissues.

Authors:  G L Stiles
Journal:  J Biol Chem       Date:  1986-08-15       Impact factor: 5.157

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Purification of the muscarinic acetylcholine receptor from porcine brain.

Authors:  K Haga; T Haga
Journal:  J Biol Chem       Date:  1985-07-05       Impact factor: 5.157

6.  Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes.

Authors:  A De Lean; A A Hancock; R J Lefkowitz
Journal:  Mol Pharmacol       Date:  1982-01       Impact factor: 4.436

7.  The A1 adenosine receptor. Solubilization and characterization of a guanine nucleotide-sensitive form of the receptor.

Authors:  G L Stiles
Journal:  J Biol Chem       Date:  1985-06-10       Impact factor: 5.157

8.  A new high affinity, iodinated adenosine receptor antagonist as a radioligand/photoaffinity crosslinking probe.

Authors:  G L Stiles; K A Jacobson
Journal:  Mol Pharmacol       Date:  1987-08       Impact factor: 4.436

9.  Adenosine stimulates guanylate cyclase activity in vascular smooth muscle cells.

Authors:  A Kurtz
Journal:  J Biol Chem       Date:  1987-05-05       Impact factor: 5.157

10.  Affinity chromatography of the D1 dopamine receptor from rat corpus striatum.

Authors:  J A Gingrich; N Amlaiky; S E Senogles; W K Chang; R D McQuade; J G Berger; M G Caron
Journal:  Biochemistry       Date:  1988-05-31       Impact factor: 3.162

View more
  12 in total

1.  Distinct pathways of desensitization of A1- and A2-adenosine receptors in DDT1 MF-2 cells.

Authors:  V Ramkumar; M E Olah; K A Jacobson; G L Stiles
Journal:  Mol Pharmacol       Date:  1991-11       Impact factor: 4.436

2.  Cloning, expression, and characterization of the unique bovine A1 adenosine receptor. Studies on the ligand binding site by site-directed mutagenesis.

Authors:  M E Olah; H Ren; J Ostrowski; K A Jacobson; G L Stiles
Journal:  J Biol Chem       Date:  1992-05-25       Impact factor: 5.157

3.  TRIFUNCTIONAL LIGANDS: A RADIOIODINATED HIGH AFFINITY ACYLATING ANTAGONIST FOR THE A1 ADENOSINE RECEPTOR.

Authors:  Kenneth A Jacobson; Mark E Olah; Gary L Stiles
Journal:  Pharmacol Commun       Date:  1992

Review 4.  Functionalized congener approach to the design of ligands for G protein-coupled receptors (GPCRs).

Authors:  Kenneth A Jacobson
Journal:  Bioconjug Chem       Date:  2009-04-30       Impact factor: 4.774

5.  The A2 adenosine receptor: guanine nucleotide modulation of agonist binding is enhanced by proteolysis.

Authors:  C Nanoff; K A Jacobson; G L Stiles
Journal:  Mol Pharmacol       Date:  1991-02       Impact factor: 4.436

6.  Solubilized rabbit striatal A2a-adenosine receptors: stability and antagonist binding.

Authors:  X D Ji; K A Jacobson
Journal:  Arch Biochem Biophys       Date:  1993-09       Impact factor: 4.013

7.  Characterization of adenosine receptor in its native environment: insights from molecular dynamics simulations of palmitoylated/glycosylated, membrane-integrated human A(2B) adenosine receptor.

Authors:  Mahboubeh Mansourian; Armin Madadkar-Sobhani; Karim Mahnam; Afshin Fassihi; Lotfollah Saghaie
Journal:  J Mol Model       Date:  2012-05-09       Impact factor: 1.810

8.  Characterization of human striatal A2-adenosine receptors using radioligand binding and photoaffinity labeling.

Authors:  X D Ji; G L Stiles; P J van Galen; K A Jacobson
Journal:  J Recept Res       Date:  1992

9.  Functionalized congener approach to muscarinic antagonists: analogues of pirenzepine.

Authors:  Y Karton; B J Bradbury; J Baumgold; R Paek; K A Jacobson
Journal:  J Med Chem       Date:  1991-07       Impact factor: 7.446

10.  Trifunctional agents as a design strategy for tailoring ligand properties: irreversible inhibitors of A1 adenosine receptors.

Authors:  D L Boring; X D Ji; J Zimmet; K E Taylor; G L Stiles; K A Jacobson
Journal:  Bioconjug Chem       Date:  1991 Mar-Apr       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.